Young-Mi Go

Has grant

Professor

Emory University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Microbiome Metabolite Valerobetaine: Mechanisms in Aging

Open Date: 2023-01-01

Close Date: 2025-01-01

Grant: Close

Cadmium-potentiated metabolic reprogramming in pathogenesis of lung fibrosis

Open Date: 2021-01-01

Close Date: 2026-01-01

Grant: Close

Vanadium in lung mitochondria oxidative stress

Open Date: 2020-01-01

Close Date: 2023-01-01

Grant: Close

Mitochondria Environmental Stress Signaling Networks

Open Date: 2015-05-07

Close Date: 2017-04-30

Grant: Close

Cytoplasmic-nuclear redox signaling: Disruption by dietary cadmium levels

Open Date: 2014-07-01

Close Date: 2019-04-30

Articles (5)

Year:

2025

Early-life respiratory syncytial virus (RSV) infection (eRSV) is a major cause of severe respiratory illness in children and increases the risk of asthma and lung dysfunction later in life. Cadmium (Cd), a toxic environmental metal, exacerbates these risks when combined with eRSV. Our previous research demonstrated that eRSV reprograms lung metabolism and amplifies Cd toxicity, driving inflammation, and metabolic disruption through protein palmitoylation. Recent studies showed that inhibiting mTORC1 with rapamycin (Rapa) mitigates Cd-induced metabolic disruption and profibrotic signaling in lung fibroblasts. In this study, we employed a mouse model to investigate the role of mTORC1 in mediating the effects of chronic low-dose Cd exposure (3.3 mg CdCl2/L in drinking water for 16 wk) following eRSV (eRSV+Cd). The impact of mTORC1 inhibition was assessed using Rapa (14 ppm), with downstream autophagy markers analyzed as indicators of mTORC1 activity. Mice in the eRSV+Cd group showed significantly elevated levels of cytokines, chemokines, inflammatory cells, and collagen deposition, indicating stimulation of inflammation and fibrosis. Rapa treatment markedly reduced these pathological markers. Metabolomic profiling and single-cell RNA sequencing revealed disruptions in autophagy-associated metabolites and genes in the eRSV+Cd group, which were reversed by Rapa. Taken together, this study highlights the critical role of the mTORC1 activation-autophagy inhibition pathway in mediating the exacerbated inflammatory response and lung fibrosis induced by Cd exposure following eRSV. These results underscore the potential of targeting the mTORC1-autophagy pathway with Rapa as a therapeutic strategy to mitigate lung damage in individuals affected by these environmental and infectious insults.

Year:

2025

Year:

2025

Interstitial lung diseases (ILDs) include a variety of inflammatory and fibrotic pulmonary conditions. This study employs high‐resolution metabolomics (HRM) to explore plasma metabolites and pathways across ILD phenotypes, including non‐fibrotic ILD, idiopathic pulmonary fibrosis (IPF), and non‐IPF fibrotic ILD. The study used 80 plasma samples for HRM, and involved linear trend and group‐wise analyses of metabolites altered in ILD phenotypes. We utilized limma one‐way ANOVA and mummichog algorithms to identify differences in metabolites and pathways across ILD groups. Then, we focused on metabolites within critical pathways, indicated by high pathway overlap sizes and low p ‐values, for further analysis. Targeted HRM identified putrescine, hydroxyproline, prolyl‐hydroxyproline, aspartate, and glutamate with significant linear increases in more fibrotic ILD phenotypes, suggesting their role in ILD fibrogenesis. Untargeted HRM highlighted pathway alterations in lysine, vitamin D3, tyrosine, and urea cycle metabolism, all associated with pulmonary fibrosis. In addition, methylparaben level had a significantly increasing linear trend and was higher in the IPF than fibrotic and non‐ILD groups. This study highlights the importance of specific amino acids, metabolic pathways, and xenobiotics in the progression of pulmonary fibrosis.

Year:

2024

Respiratory syncytial virus (RSV) infection causes serious pulmonary disease and death in high-risk infants and elderly. Cadmium (Cd) is a toxic environmental metal contaminant and constantly exposed to humans. Limited information is available on Cd toxicity after early-life respiratory virus infection. In this study, we examined the effects of low-dose Cd exposure following early-life RSV infection on lung metabolism and inflammation using mouse and fibroblast culture models. C57BL/6J mice at 8 days old were exposed to RSV 2 times with a 4-week interval. A subset of RSV-infected mice was subsequently treated with Cd at a low dose in drinking water (RSV infection at infant age [RSVinf]+Cd) for 16 weeks. The results of inflammatory marker analysis showed that the levels of cytokines and chemokines were substantially higher in RSVinf+Cd group than other groups, implying that low-dose Cd following early-life RSV infection enhanced lung inflammation. Moreover, histopathology data showed that inflammatory cells and thickening of the alveolar walls as a profibrotic signature were evident in RSVinf+Cd. The metabolomics data revealed that RSVinf+Cd-caused metabolic disruption in histamine and histidine, vitamin D and urea cycle, and pyrimidine pathway accompanying with mechanistic target of rapamycin complex-1 activation. Taken together, our study demonstrates for the first time that cumulative Cd exposure following early-life RSV infection has a significant impact on subsequent inflammation and lung metabolism. Thus, early-life respiratory infection may reprogram metabolism and potentiate Cd toxicity, enhance inflammation, and cause fibrosis later in life.

Year:

2022

Collaborators (2)

Matthew Ryan Smith

Assistant Professor of Medicine

Emory University

UNITED STATES
View details

Zachery Jarrell

Assistant Professor

Emory University

UNITED STATES
View details